After years of hard working, Creative Biolabs is now in a leading position of antibody discovery and immunotherapy. We can provide a new kind of CAR-T cells which can express PD-1 antibody and thus enhance the safety and specificity of CAR-T cell therapy. This kind of CAR-T cells overcomes the limitation on the treatment of solid tumor by combining CAR-T cells with checkpoint blockade.